• Cronos Group Inc CRON.TO reported quarterly adjusted earnings of 2 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -1 cents. The lone analyst forecast for the quarter was for a loss of one cent per share.

• Revenue rose 27.6% to $32.26 million from a year ago; analysts expected $33.00 million.

• Cronos Group Inc's reported EPS for the quarter was 2 cents​.

• The company reported quarterly net income of $6.12 million.

• Cronos Group Inc shares had risen by 2.2% this quarter and lost 8.4% so far this year.

FORECAST CHANGES

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is "hold."

• Wall Street's median 12-month price target for Cronos Group Inc is $2.43

This summary was machine generated from LSEG data May 8 at 02:10 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)